Rectal administration of warfarin (coumadin) sodium (sodium [3(2-acetonyl-benzyl)-4 hydroxycoumarin)]). - Suppr | 超能文献

相似文献

1

Rectal administration of warfarin (coumadin) sodium (sodium [3(2-acetonyl-benzyl)-4 hydroxycoumarin)]).

Proc Soc Exp Biol Med. 1956 May;92(1):52-5. doi: 10.3181/00379727-92-22382.

2

Clinical experience with warfarin (coumadin) sodium, a new anticoagulant.华法林（香豆素）钠——一种新型抗凝剂的临床经验

J Am Med Assoc. 1955 Nov 12;159(11):1094-7. doi: 10.1001/jama.1955.02960280016004.

3

Intramuscular administration of the anticoagulant warfarin (coumadin) sodium.

J Am Med Assoc. 1957 Nov 16;165(11):1377-80. doi: 10.1001/jama.1957.02980290017004.

4

Coumadin (warfarin) sodium; a new anticoagulant.

N Engl J Med. 1956 Sep 13;255(11):491-501. doi: 10.1056/NEJM195609132551101.

5

Experience with a new anticoagulant coumadin (warfarin) sodium.

Ariz Med. 1956 Oct;13(10):389-92.

6

Clinical observations on use of warfarin (coumadin) sodium, a new anticoagulant.

J Am Med Assoc. 1957 Nov 16;165(11):1381-8. doi: 10.1001/jama.1957.02980290021005.

7

Comparative clinical study of coumadin sodium and dicumarol in patients with thromboembolic diseases.华法林钠与双香豆素治疗血栓栓塞性疾病患者的对比临床研究。

Am Heart J. 1958 Jan;55(1):66-72. doi: 10.1016/0002-8703(58)90256-4.

8

Experience with a new intravenous coumarin anticoagulant (warfarin, sodium derivative).

Proc Staff Meet Mayo Clin. 1953 Sep 9;28(18):489-97.

9

[Anticoagulant properties and therapeutic use of a new coumarin derivative: 3-[2-acetyl-1-(p-nitrophenol)-ethyl]-4-hydroxycoumarin or coumarin G 23350].一种新型香豆素衍生物：3-[2-乙酰基-1-(对硝基苯酚)-乙基]-4-羟基香豆素或香豆素G 23350的抗凝血特性及治疗用途

Therapie. 1956;11(1):85-101.

10

[Antibacterial activity of compounds possessing a tricarbonylmethane group. X. Observations on the acetylation of 4-hydroxycoumarin and synthesis of 3-(alpha-aminophenylacetyl)-4-hydroxycoumarins].[具有三羰基甲烷基团的化合物的抗菌活性。X. 4-羟基香豆素乙酰化反应的观察及3-(α-氨基苯乙酰基)-4-羟基香豆素的合成]

Pharm Bull. 1953 Dec;1(4):331-4. doi: 10.1248/cpb1953.1.331.